← Back to Intel
Insider ActivityTARA
Zummo Jacqueline, Chief R&D Officer at Protara Therapeutics, Inc., sold $119K of TARA
Updated Jun 14, 2026
Zummo Jacqueline
Chief R&D Officer
Protara Therapeutics, Inc. ·
$TARA
Transaction Details
| Insider | Zummo Jacqueline |
|---|---|
| Title | Chief R&D Officer |
| Company | Protara Therapeutics, Inc. |
| Ticker | TARA |
| Transaction Type | Sale |
| Transaction Date | 2026-04-01 |
| Shares Traded | 22,598 |
| Price Per Share | $5.26 |
| Total Value | $119K |
| Filed Date | 2026-04-02 |
| Accession Number | 0001213900-26-039328 |
Ownership Context
| Shares Owned After Transaction | 95,961 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001213900-26-039328
Other Insider Trades — TARA
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| CONKLING WILLIAM | Chief Commercial Officer | traded | $26K | 2026-06-02 |
| Zummo Jacqueline | Chief R&D Officer | sold | $6K | 2026-04-08 |
Other Trades by Zummo Jacqueline
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | sold | $6K | 2026-04-08 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for TARA — Protara Therapeutics, Inc. →
Track TARA insider activity in real time on The Wire →
Get alerts when Zummo Jacqueline files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:19 UTC